Atoxtrin Capsule
PDF Leaflet Revision Date: 19 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of ADHD in children, adolescents, and adults.
Dosage (summary)
Initial dose: 0.5 mg/kg for children <70 kg; 40 mg for those u226570 kg and adults. Maintenance: 1.2 mg/kg/day or 80 mg max.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to insufficient safety data.
Key Drug Interactions
- MAOIs
- CYP2D6 inhibitors
- Serotonergic medications
Contraindications
- Hypersensitivity to atomoxetine
- Narrow-angle glaucoma
- Severe cardiovascular disorders
Common side effects
- Decreased appetite
- Headache
- Nausea
- Fatigue
Counselling Points
- Monitor for mood changes
- Avoid driving if affected
- Do not open capsules
Serious warnings
- Increased risk of suicidal ideation in children and adolescents
- Cardiovascular effects
- Potential for liver injury
Important Disclaimer
The Atoxtrin Capsule professional information leaflet below is the property of Trinity Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
